| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/25/2012 | CN101906137B Conjugate of Arg-Gly-Asp chain and two fatty alcohol chains, synthesis and medical application thereof |
| 01/25/2012 | CN101897667B Doxorubicin hydrochloride liposome injection and preparation technology thereof |
| 01/25/2012 | CN101884627B Pioglitazone hydrochloride gastric retentive sustained release tablet and preparation method thereof |
| 01/25/2012 | CN101874789B Lansoprazole-contained freeze-dried powder injection |
| 01/25/2012 | CN101869552B Preparation method of chitin tablet |
| 01/25/2012 | CN101842075B Cosmetic auxiliary patch material and method of cosmetizing therewith |
| 01/25/2012 | CN101829333B New multi-functional auxiliary material for orally disintegrating tablets and preparation method thereof |
| 01/25/2012 | CN101829063B Lung targeting microsphere of veterinary ceftiofur hydrochloride and preparation method |
| 01/25/2012 | CN101812227B Micelle based on non-linear polyethylene glycol-polylactic acid block copolymer and preparation method thereof |
| 01/25/2012 | CN101810581B Method for enhancing content uniformity of clenbuterol hydrochloride and application thereof |
| 01/25/2012 | CN101797388B Matrix of suppository or paste medicine for treating prostatitis and preparation method thereof |
| 01/25/2012 | CN101787120B Triblock polyamino acid and hydrogel thereof |
| 01/25/2012 | CN101785764B Method for improving blood compatibility of microcapsule |
| 01/25/2012 | CN101785759B Nanoparticle for embedding medicinal Adriamycin as well as preparation method and application thereof |
| 01/25/2012 | CN101780083B Calcium folinate and phenyl alanine composition and preparation method thereof |
| 01/25/2012 | CN101721713B Cyclodextrin inclusion compound of 3,5-dyhydroxyl-4-isopropyl toluylene and preparation method thereof |
| 01/25/2012 | CN101721677B Thymopentin oral microsphere preparation and preparation method thereof |
| 01/25/2012 | CN101721500B Composition and preparation method and application thereof |
| 01/25/2012 | CN101721410B Solid medicinal composition of clopidogrel hydrogen sulfate |
| 01/25/2012 | CN101717432B Polyglutamic acid and application thereof in processing medicine, cosmetics, food and water |
| 01/25/2012 | CN101703751B Emplastrum for treating white-plus disease and preparation method thereof |
| 01/25/2012 | CN101695483B Independently controllable contraceptive transdermal patch containing progestogen and estrogen and preparation method thereof |
| 01/25/2012 | CN101690573B Production method of fructus monordicae extract with over 60% of mogroside V content |
| 01/25/2012 | CN101664448B Acne ointment as well as preparation method and quality detection method thereof |
| 01/25/2012 | CN101664396B Azithromycin soft capsules and preparation method thereof |
| 01/25/2012 | CN101658668B Method and application for preparing bacteria simulacrum by using antibacterial peptide |
| 01/25/2012 | CN101632737B Medicament for relieving pain of human body and preparation method thereof |
| 01/25/2012 | CN101612170B Compound injection of Ginkgo Biloba extract and dipyridamole and preparation technology thereof |
| 01/25/2012 | CN101595874B Validamycin amphiphilic polymer network and synthesis method thereof |
| 01/25/2012 | CN101579323B Butylphenyl phthaleine sustained release tablet and preparation method thereof |
| 01/25/2012 | CN101450209B Preparation method of transdermal immune influenza multivalent vaccine |
| 01/25/2012 | CN101301467B Uses of BMP-7 in preparing medicament for preventing and/or treating liver fibrosis |
| 01/25/2012 | CN101269067B Antibacterial gynecology externally used pharmaceutical combination |
| 01/25/2012 | CN101193683B Cosmetic towelette product |
| 01/25/2012 | CN101085355B 5-flucytosine/hydrotalcite-like nano hybrid compound and preparation method thereof |
| 01/24/2012 | US8103517 System and method to improve fitness training |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101575 Glycopeptide phosphonate derivatives |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | US8101208 Sensate compositions and delivery systems therefor |
| 01/24/2012 | US8101207 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |
| 01/24/2012 | US8101201 Compositions comprising dietary fat complexer and methods for their use |
| 01/24/2012 | US8101196 Medical gel; crosslinking |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | US8101180 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
| 01/24/2012 | US8101172 Solenopsis invicta virus |
| 01/24/2012 | US8101170 Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof |
| 01/24/2012 | US8101164 Dual phase drug release system |
| 01/24/2012 | US8101163 Transdermal compositions |
| 01/24/2012 | US8101160 Formulations for use in inhaler devices |
| 01/24/2012 | CA2661099C Pharmaceutical compositions comprising cefquinome |
| 01/24/2012 | CA2592102C Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same |
| 01/24/2012 | CA2579810C Stable pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 01/24/2012 | CA2527499C Foamable pharmaceutical compositions and methods for treating a disorder |
| 01/24/2012 | CA2515426C Uses and formulations for transdermal or transmucosal application of active agents |
| 01/24/2012 | CA2496249C 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 01/24/2012 | CA2494761C Oral pharmaceutical compositions comprising cyclosporin |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2478825C Composition having gelling properties for the prolonged delivery of bioactive substances |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2432151C Compositions of estrogen-cyclodextrin complexes |
| 01/24/2012 | CA2324901C Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/24/2012 | CA2269078C Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/24/2012 | CA2221730C Use of angiotensin ii type 2 receptor agonists in tissue repair |
| 01/20/2012 | CA2735631A1 Curcumin formulations and methods for making such formulations |
| 01/19/2012 | WO2012009707A2 Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| 01/19/2012 | WO2012009474A1 Method and formulations for treating sialic acid deficiencies |
| 01/19/2012 | WO2012009448A2 Cationic polymer coated mesoporous silica nanoparticles and uses thereof |
| 01/19/2012 | WO2012009080A2 Device for radiation-activated localized delivery of treatment agents |
| 01/19/2012 | WO2012009048A1 Dual drug delivery using silicone gels |
| 01/19/2012 | WO2012008869A1 Aprotinin-based aerosol preparation for the treatment of viral respiratory infections |
| 01/19/2012 | WO2012008845A1 Parenteral formulations of elacytarabine derivatives |
| 01/19/2012 | WO2012008782A2 Use of carbon nanotubes for preventing or treating brain disease |
| 01/19/2012 | WO2012008779A2 A liquid formulation of long-acting human growth hormone conjugate |
| 01/19/2012 | WO2012008465A1 (nucleic acid)-polysaccharide complex |
| 01/19/2012 | WO2012008396A1 Patch support for water-based plaster |
| 01/19/2012 | WO2012008271A1 Oil-based gel-like composition |
| 01/19/2012 | WO2012008159A1 Solid dispersion of alfa-ketoamide derivatives |
| 01/19/2012 | WO2012007906A2 Eudermic compositions |
| 01/19/2012 | WO2012007896A1 Multifunctional antibody conjugates |
| 01/19/2012 | WO2012007584A2 Composition for the treatment of superficial lesions |
| 01/19/2012 | WO2012007570A2 New formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | WO2012007517A1 Formulations of 14 - epi -analogues of vitamin d |
| 01/19/2012 | WO2012007512A1 New formulations of 14 - epi -analogues of vitamin d |
| 01/19/2012 | WO2012007324A2 Stabilized factor viii variants |
| 01/19/2012 | WO2012006967A1 Poly(ethylene oxide) and base surfactant in suppository composition |
| 01/19/2012 | WO2012006965A1 Tablet with improved comprehensive performance and preparation method therefor |
| 01/19/2012 | WO2012006963A1 Polymer reinforcing agent in controlled release preparation |
| 01/19/2012 | WO2012006961A1 Controlled release formulation |
| 01/19/2012 | WO2012006938A1 Pharmaceutical composition capable of targeted release of trace element, and preparation method and application of pharmaceutical composition |
| 01/19/2012 | WO2012006780A1 Phthalocyanine-serum albumin complex, method for preparation and use thereof |
| 01/19/2012 | WO2012006683A1 Pharmaceutical compositions for sustained delivery of benzodiazepine antagonists |
| 01/19/2012 | WO2011153493A3 Biodegradable lipids for the delivery of active agents |
| 01/19/2012 | WO2011147762A3 Stabilized radiopharmaceutical composition |
| 01/19/2012 | WO2011126537A3 Oral adhering compositions that apply rhizophora mangle extract in the mouth |
| 01/19/2012 | WO2011112549A3 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/19/2012 | WO2011110694A3 Micelle compositions and process for the preparation thereof |
| 01/19/2012 | WO2011109106A3 Immunogenic compositions against human progastrin peptides |